Literature DB >> 19457120

Cell entry strategy of clostridial neurotoxins.

Thomas Binz1, Andreas Rummel.   

Abstract

Tetanus neurotoxin and botulinum neurotoxins are the causative agents of tetanus and botulism. They block the release of neurotransmitters from synaptic vesicles in susceptible animals and man and act in nanogram quantities because of their ability to specifically attack motoneurons. They developed an ingenious strategy to enter neurons. This involves a concentration step via complex polysialo gangliosides at the plasma membrane and the uptake and ride in recycling synaptic vesicles initiated by binding to a specific protein receptor. Finally, the neurotoxins shut down the synaptic vesicle cycle, which they had misused before to enter their target cells, via specific cleavage of protein core components of the cellular membrane fusion machinery. The uptake of four out of seven known botulinum neurotoxins into synaptic vesicles has been demonstrated to rely on binding to intravesicular segments of the synaptic vesicle proteins synaptotagmin or synaptic vesicle protein 2. This review summarizes the present knowledge about the cell receptor molecules and the mode of toxin-receptor interaction that enables the toxins' sophisticated access to their site of action.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19457120     DOI: 10.1111/j.1471-4159.2009.06093.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  71 in total

1.  The case of botulinum toxin in milk: experimental data.

Authors:  Oliver G Weingart; Tanja Schreiber; Conny Mascher; Diana Pauly; Martin B Dorner; Thomas F H Berger; Charlotte Egger; Frank Gessler; Martin J Loessner; Marc-Andre Avondet; Brigitte G Dorner
Journal:  Appl Environ Microbiol       Date:  2010-04-02       Impact factor: 4.792

2.  SNARE tagging allows stepwise assembly of a multimodular medicinal toxin.

Authors:  Frédéric Darios; Dhevahi Niranjan; Enrico Ferrari; Fan Zhang; Mikhail Soloviev; Andreas Rummel; Hans Bigalke; Jason Suckling; Yuri Ushkaryov; Nikolay Naumenko; Anastasia Shakirzyanova; Rashid Giniatullin; Elizabeth Maywood; Michael Hastings; Thomas Binz; Bazbek Davletov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

3.  Membrane interaction of Pasteurella multocida toxin involves sphingomyelin.

Authors:  Michael C Brothers; Mengfei Ho; Ram Maharjan; Nathan C Clemons; Yuka Bannai; Mark A Waites; Melinda J Faulkner; Theresa B Kuhlenschmidt; Mark S Kuhlenschmidt; Steven R Blanke; Chad M Rienstra; Brenda A Wilson
Journal:  FEBS J       Date:  2011-10-20       Impact factor: 5.542

Review 4.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

5.  Studies of the mechanistic details of the pH-dependent association of botulinum neurotoxin with membranes.

Authors:  Darren J Mushrush; Hanane A Koteiche; Morgan A Sammons; Andrew J Link; Hassane S McHaourab; D Borden Lacy
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

Review 6.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

7.  The structure of the tetanus toxin reveals pH-mediated domain dynamics.

Authors:  Geoffrey Masuyer; Julian Conrad; Pål Stenmark
Journal:  EMBO Rep       Date:  2017-06-23       Impact factor: 8.807

8.  Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.

Authors:  Jasmin Strotmeier; Stefan Mahrhold; Nadja Krez; Constantin Janzen; Jianlong Lou; James D Marks; Thomas Binz; Andreas Rummel
Journal:  FEBS Lett       Date:  2014-02-25       Impact factor: 4.124

Review 9.  Interaction of botulinum toxin with the epithelial barrier.

Authors:  Yukako Fujinaga
Journal:  J Biomed Biotechnol       Date:  2010-02-14

10.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.